How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chronic-lymphocyticleukemia-small-lymphocytic-lymphoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chronic lymphocyticleukemia/small lymphocytic lymphoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic lymphocyticleukemia/small lymphocytic lymphoma (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chronic lymphocyticleukemia/small lymphocytic lymphoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Calquence	ACALABRUTINIB	AstraZeneca	Kinase Inhibitor [EPC]	Tyrosine-protein kinase BTK		2017-01-01
Calquence	Calquence	iOMEDICO AG		Platelet glycoprotein VI, Cytoplasmic tyrosine-protein kinase BMX, Tyrosine-protein kinase Blk

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AstraZeneca · 1 drug in Chronic lymphocyticleukemia/small lymphocytic lymphoma
iOMEDICO AG · 1 drug in Chronic lymphocyticleukemia/small lymphocytic lymphoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chronic lymphocyticleukemia/small lymphocytic lymphoma:

Cite this brief

Drug Landscape (2026). Chronic lymphocyticleukemia/small lymphocytic lymphoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-lymphocyticleukemia-small-lymphocytic-lymphoma. Accessed 2026-06-10.

Chronic lymphocyticleukemia/small lymphocytic lymphoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing